Pneumococcal Conjugate Vaccine (13-Valent) and Zoladex (Goserelin Implant 3.6 mg)
Determining the interaction of Pneumococcal Conjugate Vaccine (13-Valent) and Zoladex (Goserelin Implant 3.6 mg) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: pneumococcal 13-valent vaccine
Brand name: Prevnar 13
Synonyms: Pneumococcal 13-valent conjugate vaccine
Generic Name: goserelin
Brand name: Zoladex
Synonyms: Zoladex
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Pneumococcal Conjugate Vaccine (13-Valent)-Zoladex 3-Month
- Pneumococcal Conjugate Vaccine (13-Valent)-Zoladex Implant
- Pneumococcal Conjugate Vaccine (13-Valent)-Zolate
- Pneumococcal Conjugate Vaccine (13-Valent)-Zoledronic acid
- Pneumococcal Conjugate Vaccine (13-Valent)-Zoledronic Acid (Bone Health)
- Pneumococcal Conjugate Vaccine (13-Valent)-Zoledronic Acid (Zometa)
- Zoladex (Goserelin Implant 3.6 mg)-Pneumococcal Conjugate Vaccine (7-Valent)
- Zoladex (Goserelin Implant 3.6 mg)-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Zoladex (Goserelin Implant 3.6 mg)-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Zoladex (Goserelin Implant 3.6 mg)-Pneumovax 23
- Zoladex (Goserelin Implant 3.6 mg)-PNV - Omega
- Zoladex (Goserelin Implant 3.6 mg)-PNV Iron Polysaccharides, Folic Acid, DHA